InterCure to Hold 2021 Q4 & Year-End Webcast
InterCure Ltd (NASDAQ: INCR) announced the release of its fourth quarter 2021 financial results on March 31, 2022, with a subsequent webcast scheduled for April 4, 2022, at 8:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InterCure Ltd (NASDAQ: INCR) announced the release of its fourth quarter 2021 financial results on March 31, 2022, with a subsequent webcast scheduled for April 4, 2022, at 8:30 a.m. ET. The company, a leading cannabis producer in Israel, highlights its growth strategy and recent milestones. InterCure operates through its subsidiary, Canndoc, which is the largest licensed cannabis producer in Israel. The company emphasizes its high-margin, vertically integrated model and market-leading distribution network.
Positive
- Leading cannabis company in Israel with strong market position.
- Profitable and fastest-growing cannabis operation outside North America.
- High-margin vertically integrated 'seed-to-sale' model.
- Largest licensed cannabis producer in Israel.
Negative
- None.
Details
News Market Reaction – INCR
The recorded move for INCR in the trading session of this news was +0.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Webcast scheduled for Monday, April 4, 2022, at 8:30am ET
NEW YORK, TORONTO, and HERZLIYA, Israel, March 30, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that it plans to release financial results for the fourth quarter of 2021 after market close on Thursday, March 31, 2022. The Company will conduct a webcast on Monday, April 4, 2022 at 8:30 a.m. (Eastern Time) to review the results as well as provide an overview of the Company’s recent milestones and growth strategy.
To access the conference call, United States participants please dial (844) 310-5056, or for international callers, 1-706-679-4749. Conference ID: 5661207.
Participants can access the live webcast through the following link:
https://bit.ly/37N92wN
A live webcast of the conference call can be accessed on the ‘Events and Presentations’ section of the InterCure website at http://www.intercure.co.
About InterCure (dba Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.
For more information, visit: http://www.intercure.co.
Contact:
InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@intercure.co
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.